4.7 Review

Review article: prognostic significance of body composition abnormalities in patients with cirrhosis

Journal

ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 52, Issue 4, Pages 600-618

Publisher

WILEY
DOI: 10.1111/apt.15927

Keywords

-

Funding

  1. Canadian Liver Foundation (CLF)
  2. Canadian Institutes of Health Research (CIHR) - Institute of Nutrition, Metabolism and Diabetes (INMD) [HGY-164788]
  3. Canadian National Transplant Research Program (CNTRP), ATIF Innovation Grant Award 2018
  4. University of Alberta Hospital Foundation (UHF)

Ask authors/readers for more resources

Background Recent advances in evaluation of body composition show body mass index to be inadequate in differentiating between body compartments in cirrhosis. Given the limitations of body mass index, body composition evaluation using computed tomography has been increasingly used as a non-invasive clinical tool with prognostic value. Another factor influencing prognosis includes sex-specific differences in body composition that are seen in cirrhosis. Aim To review current knowledge regarding the frequency and clinical implications of abnormal body composition features in cirrhosis. Methods We searched PubMed database and limited the literature search to full-text papers published in English. The expertise of review authors in analysing body composition was used to eliminate studies using inappropriate landmarks or demarcation of body composition components on computed tomography images. Results Sarcopenia is a well established factor affecting morbidity and mortality in cirrhosis. Other important body composition components that have been over looked thus far include subcutaneous adipose tissue and visceral adipose tissue. Female patients with cirrhosis and low subcutaneous adiposity have a higher risk of mortality, whereas male patients with high visceral adiposity have a higher risk of hepatocellular carcinoma and recurrence following liver transplantation. Increased adipose tissue radiodensity has been associated with risk of decompensation and mortality. Conclusions Further evaluation of body composition abnormalities may help with development of targeted therapeutic strategies and improve outcome in patients with cirrhosis. Moreover, recognition of these abnormalities could improve prioritisation for liver transplantation as our current method based solely on liver function might lead to risk misclassification.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available